LY

Leon (Chu-Hsiang) Yu

Senior Manager, CMC Project Management at Scribe Therapeutics

Leon (Chu-Hsiang) Yu has worked in a variety of roles in the scientific and research fields for the past nine years. In 2023, they began working as a Senior Manager of CMC Project Management at Scribe Therapeutics. From 2019 to 2023, they worked as a Senior Project Manager and Project Manager II, Gene/Cell Therapy, Process Development at Pall Corporation. Leon (Chu-Hsiang)'srole included collaboration with CDMOs, providing business and project management support, advocating the use of Pall single-use bioreactors, delivering process development proposals, managing project timelines and budgets, and presenting strategic plan presentations to clients. From 2017 to 2019, they worked as a Research Scientist/R&D Project Manager at Northeastern University. From 2015 to 2017, they worked as a Research Specialist/R&D Project Manager at the University of Connecticut, where they managed five teams to develop a 3D-printed microfluidic chip, managed two teams utilizing 3D bio-printing and magnetic assembly for three tissue engineering projects, developed two types of portable medical devices, collaborated with multi-functional teams at five institutions, and designed 3D illustrations for manuscripts and presentations. From 2012 to 2015, they worked at Harvard Medical School as a Research Assistant/Project Coordinator and a Biomedical Engineering Program Trainee. Leon (Chu-Hsiang)'srole included managing tight project schedules, developing Point-of-Care devices, collaborating with MIT to develop a new vitrification process of cell bio-preservation, and applying acoustic wave expertise to create picoliter-sized droplets that encapsulate single cells.

Leon (Chu-Hsiang) Yu has a Master's degree in Chemistry from Brandeis University and a Bachelor of Science (BS) in Medicinal and Applied Chemistry from Kaohsiung Medical University. Leon (Chu-Hsiang) also holds a Research Trainee certification from Brigham and Women's Hospital in the Biomedical Engineering Division.

Location

San Francisco, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Scribe Therapeutics

1 followers

Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.


Employees

51-200

Links